Exact Mass: 358.1917
Exact Mass Matches: 358.1917
Found 132 metabolites which its exact mass value is equals to given mass value 358.1917,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-(3,7,11-Trimethyldodeca-2,6,10-trienylsulfanyl)benzoic acid
2-[(3,7,11-Trimethyldodeca-2,6,10-trien-1-yl)sulphanyl]benzoic acid
4,4'-Thiobis(6-tert-butyl-m-cresol)
2-tert-butyl-4-[(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl]-5-methylphenol
Itopride
N-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)-3,4-dimethoxybenzene-1-carboximidate
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
Itopride
Itopride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS
S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS
yohimbinic acid
(1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2,3:3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid hydrate
Yohimbic acid hydrate is an amphoteric demethylated derivative of Yohimbine (HY-12715). Yohimbic acid hydrate exhibits vasodilatory action. Yohimbic acid hydrate also can be used for the research of osteoarthritis (OA)[1][2][3].
Ala Ala Pro Thr
(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid
Ala Ala Thr Pro
(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid
Ala Pro Ala Thr
(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-hydroxybutanoic acid
Ala Pro Thr Ala
(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]propanoic acid
Ala Thr Ala Pro
(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]propanoyl]pyrrolidine-2-carboxylic acid
Ala Thr Pro Ala
(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}propanoic acid
Gly Pro Ser Val
(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-methylbutanoic acid
Gly Pro Val Ser
(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-hydroxypropanoic acid
Gly Ser Pro Val
(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid
Gly Ser Val Pro
(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid
Gly Val Pro Ser
(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid
Gly Val Ser Pro
(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid
Pro Ala Ala Thr
(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid
Pro Ala Thr Ala
(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid
Pro Gly Ser Val
(2S)-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-methylbutanoic acid
Pro Gly Val Ser
(2S)-3-hydroxy-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]propanoic acid
Pro Ser Gly Val
(2S)-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-methylbutanoic acid
Pro Ser Val Gly
2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]acetic acid
Pro Thr Ala Ala
(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid
Pro Val Gly Ser
(2S)-3-hydroxy-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}propanoic acid
Pro Val Ser Gly
2-[(2S)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]acetic acid
Ser Gly Pro Val
(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid
Ser Gly Val Pro
(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid
Ser Pro Gly Val
(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid
Ser Pro Val Gly
2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid
Ser Val Gly Pro
(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid
Ser Val Pro Gly
2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid
Thr Ala Ala Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid
Thr Ala Pro Ala
(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid
Thr Pro Ala Ala
(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid
Val Gly Pro Ser
(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid
Val Gly Ser Pro
(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid
Val Pro Gly Ser
(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanoic acid
Val Pro Ser Gly
2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]acetic acid
Val Ser Gly Pro
(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid
Val Ser Pro Gly
2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetic acid
Salirasib
2-[[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]thio]-benzoic acid
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.
2-Methyl-2-propanyl 2-benzyl-1,3-dioxo-2,8-diazaspiro[4.5]decane- 8-carboxylate
2-Methyl-2-propanyl 2-benzyl-1,3-dioxo-2,8-diazaspiro[4.5]decane- 8-carboxylate
1-BOC-2-[(2-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(2-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(3-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(3-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(4-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(4-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
B-[3,5-Difluoro-4-(trans-4-propylcyclohexyl)[1,1-biphenyl]-4-yl]boronic acid
B-[3,5-Difluoro-4-(trans-4-propylcyclohexyl)[1,1-biphenyl]-4-yl]boronic acid
7,8,9,10,18,19,20,21-Octahydro-6H,17H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine
7,8,9,10,18,19,20,21-Octahydro-6H,17H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine
1,9-Diazaspiro[5.5]undecane, 1-(phenylmethyl)-, 2,2,2-trifluoroacetate (1:1)
1,9-Diazaspiro[5.5]undecane, 1-(phenylmethyl)-, 2,2,2-trifluoroacetate (1:1)
N2-[(Benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-YL]-L-leucinamide
N2-[(Benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-YL]-L-leucinamide
Ala-Thr-Ala-Pro
Ala-Thr-Ala-Pro
A tetrapeptide composed of L-alanine, L-threonine, L-alanine, and L-proline joined in sequence by peptide linkages.
1-butyl-1-methyl-3-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)thiourea
1-butyl-1-methyl-3-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)thiourea
N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
5-[(3,4-dimethylphenoxy)methyl]-N-methyl-N-(4-oxanylmethyl)-3-isoxazolecarboxamide
5-[(3,4-dimethylphenoxy)methyl]-N-methyl-N-(4-oxanylmethyl)-3-isoxazolecarboxamide
(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-3-(phenylmethyl)-3,6-diazabicyclo[3.1.1]heptane
(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-3-(phenylmethyl)-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-6-[(4-fluorophenyl)methyl]-7-(4-phenylphenyl)-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-6-[(4-fluorophenyl)methyl]-7-(4-phenylphenyl)-3,6-diazabicyclo[3.1.1]heptane
19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
A prostanoid that is 2,3-dinor-6-oxo-prostaglandin F1alpha in which a hydrogen at position 19 is replaced by a hydroxy group.
(1S,2S,6R,7R)-6-ethyl-1,6-dimethoxyspiro[10-oxa-5-azatricyclo[5.3.1.04,8]undecane-2,3-indole]-2-one
(1S,2S,6R,7R)-6-ethyl-1,6-dimethoxyspiro[10-oxa-5-azatricyclo[5.3.1.04,8]undecane-2,3-indole]-2-one
FTIDC
FTIDC
FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].
(2r,3r,4r)-4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
(2r,3r,4r)-4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
(3s,4r,5s,6s,7r)-4,5,6,7-tetrahydroxy-3-(1-hydroxydecyl)-4,5,6,7-tetrahydro-3h-2-benzofuran-1-one
(3s,4r,5s,6s,7r)-4,5,6,7-tetrahydroxy-3-(1-hydroxydecyl)-4,5,6,7-tetrahydro-3h-2-benzofuran-1-one
20-hydroxydihydrorankinidine
NA
{"Ingredient_id": "HBIN003409","Ingredient_name": "20-hydroxydihydrorankinidine","Alias": "NA","Ingredient_formula": "C20H26N2O4","Ingredient_Smile": "CCC1(CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC)O","Ingredient_weight": "358.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10009","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101606432","DrugBank_id": "NA"}
6'-ethyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
6'-ethyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
7'-ethyl-7'-hydroxy-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
7'-ethyl-7'-hydroxy-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
(1'r,3s,4's,7'r,8'r,9's)-7'-ethyl-7'-hydroxy-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
(1'r,3s,4's,7'r,8'r,9's)-7'-ethyl-7'-hydroxy-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
methyl (2r,3s,3as,4s,5r,7s,7ar)-2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate
methyl (2r,3s,3as,4s,5r,7s,7ar)-2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate
(1'r,3r,4'r,7'r,9'r,10'r)-7'-ethyl-10'-(hydroxymethyl)-1-methoxy-5'-oxa-11'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,⁹]undecan]-2-one
(1'r,3r,4'r,7'r,9'r,10'r)-7'-ethyl-10'-(hydroxymethyl)-1-methoxy-5'-oxa-11'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,⁹]undecan]-2-one
3-[5-hydroxy-3-methoxy-1-(phenylimino)hexyl]-5-(propan-2-ylidene)pyrrole-2,4-diol
3-[5-hydroxy-3-methoxy-1-(phenylimino)hexyl]-5-(propan-2-ylidene)pyrrole-2,4-diol
3-[(3r,5s)-5-hydroxy-3-methoxy-1-(phenylimino)hexyl]-5-(propan-2-ylidene)pyrrole-2,4-diol
3-[(3r,5s)-5-hydroxy-3-methoxy-1-(phenylimino)hexyl]-5-(propan-2-ylidene)pyrrole-2,4-diol
(1's,3s,6'r,7'r)-6'-ethyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
(1's,3s,6'r,7'r)-6'-ethyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
(2s)-1-[(2s)-2-{[(2s,3r)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,3-dihydroxybutylidene]amino}propanoyl]pyrrolidine-2-carboxylic acid
(2s)-1-[(2s)-2-{[(2s,3r)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,3-dihydroxybutylidene]amino}propanoyl]pyrrolidine-2-carboxylic acid
6'-ethyl-6'-(hydroxymethyl)-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
6'-ethyl-6'-(hydroxymethyl)-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
2,6-bis(1-methoxy-2-methylpropyl)-1h,5h-pyrrolo[2,3-f]indole-4,8-dione
2,6-bis(1-methoxy-2-methylpropyl)-1h,5h-pyrrolo[2,3-f]indole-4,8-dione
methyl 2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate
methyl 2-(acetyloxy)-3a,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylate
3-[(3s,5s)-5-hydroxy-3-methoxy-1-(phenylimino)hexyl]-5-(propan-2-ylidene)pyrrole-2,4-diol
3-[(3s,5s)-5-hydroxy-3-methoxy-1-(phenylimino)hexyl]-5-(propan-2-ylidene)pyrrole-2,4-diol
(1'r,3s,4's,6'r,7'r,8's)-6'-ethyl-6'-(hydroxymethyl)-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
(1'r,3s,4's,6'r,7'r,8's)-6'-ethyl-6'-(hydroxymethyl)-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one
7'-ethyl-10'-(hydroxymethyl)-1-methoxy-5'-oxa-11'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,⁹]undecan]-2-one
7'-ethyl-10'-(hydroxymethyl)-1-methoxy-5'-oxa-11'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,⁹]undecan]-2-one
2-[(1r)-1-methoxy-2-methylpropyl]-6-[(1s)-1-methoxy-2-methylpropyl]-1h,5h-pyrrolo[2,3-f]indole-4,8-dione
2-[(1r)-1-methoxy-2-methylpropyl]-6-[(1s)-1-methoxy-2-methylpropyl]-1h,5h-pyrrolo[2,3-f]indole-4,8-dione
